ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$5.85 USD
-0.20 (-3.31%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $5.86 +0.01 (0.17%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Earnings News For ALXO
-
ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
-
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
-
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
-
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights